HLA specific Antibody Detection Systems
Details
- Supplier(s)
- Werfen UK Ltd, VH Bio Ltd
- Value
- GBP 642,000
- Topic
- Diagnostic kits
- Published
- 22 April 2025
Tender description
The Histocompatibility and Immunology (H&I) department in SNBTS requires a contract for Human Leukocyte Antigen (HLA) Antibody detection kits, consumables and maintenance for existing equipment. Lot 1: HLA Specific Antibody Detection Systems - Testing kits and consumables, The Histocompatibility and Immunology (H&I) department in SNBTS requires a contract for Human Leukocyte Antigen (HLA) specific Antibody testing. SNBTS own existing equipment previously acquired via capital purchase. Testing kits and consumables are required to perform the necessary tests. HLA antibody testing is performed on solid organ transplant patients during transplant work up, while listed for a deceased donor organ and in the post-transplant setting. HLA antibody testing informs pre-transplant risk assessment and clinical decision making including the immune risk associated with proceeding with a transplant, use of immunosuppression, biopsy indication/interpretation, and the likelihood of a patient being offered a compatible offer. HLA antibody testing is also used in the transfusion setting to manage patients with immune platelet refractoriness and in the investigation of suspected cases of transfusion associated acute lung injury. Lot 2: HLA Antibody detection - consumable and maintenance of existing equipment The Histocompatibility and Immunology (H&I) department in SNBTS requires a contract for Human Leukocyte Antigen (HLA) specific Antibody testing. SNBTS own existing equipment previously acquired via capital purchase. Maintenance and associated consumables are required for this equipment. HLA antibody testing is performed on solid organ transplant patients during transplant work up, while listed for a deceased donor organ and in the post-transplant setting. HLA antibody testing informs pre-transplant risk assessment and clinical decision making including the immune risk associated with proceeding with a transplant, use of immunosuppression, biopsy indication/interpretation, and the likelihood of a patient being offered a compatible offer. HLA antibody testing is also used in the transfusion setting to manage patients with immune platelet refractoriness and in the investigation of suspected cases of transfusion associated acute lung injury.
Timeline
- Completed: Award published22 April 2025Current notice
- Completed: Award date22 April 2025
About the buyer
NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33141625 · Diagnostic kits
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov |
1 similar open tenders
See more open tenders related to HLA specific Antibody Detection Systems.
Related buyers
Buyers similar to NHS National Services Scotland.
- 19£4.6m
- 9£1.1m
- 6£445.5k
- 4£964.7k
- 2£252.0k
- 1£4.4m
- 747£1.9bn
- 231£2.0bn
- 138£1.4bn
- 135£63.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
